Mind Medicine (MindMed)
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MNMD and other ETFs, options, and stocks.About MNMD
Mind Medicine (MindMed), Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L.
CEORobert Barrow
CEORobert Barrow
Employees74
Employees74
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2010
Founded2010
Employees74
Employees74
MNMD Key Statistics
Market cap536.31M
Market cap536.31M
Price-Earnings ratio-7.02
Price-Earnings ratio-7.02
Dividend yield—
Dividend yield—
Average volume1.97M
Average volume1.97M
High today$14.99
High today$14.99
Low today$13.81
Low today$13.81
Open price$14.70
Open price$14.70
Volume2.06M
Volume2.06M
52 Week high$15.29
52 Week high$15.29
52 Week low$4.70
52 Week low$4.70
Stock Snapshot
The current Mind Medicine (MindMed)(MNMD) stock price is $13.99, with a market capitalization of 536.31M. The stock trades at a price-to-earnings (P/E) ratio of -7.02.
On 2026-01-11, Mind Medicine (MindMed)(MNMD) stock moved within a range of $13.81 to $14.99. With shares now at $13.99, the stock is trading +1.3% above its intraday low and -6.7% below the session's peak.
Trading activity shows a volume of 2.06M, compared to an average daily volume of 1.97M.
The stock's 52-week range extends from a low of $4.70 to a high of $15.29.
The stock's 52-week range extends from a low of $4.70 to a high of $15.29.
Analyst ratings
100%
of 13 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own MNMD. This list is generated using Robinhood data, and it’s not a recommendation.